Overview
Axel Seher practices practicing medicine in Wuerzburg, Germany.
His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, and Necrosis.
He is actively involved in clinical research, co-authoring 35 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Axel Seher
Is Axel Seher a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Axel Seher is classified as an Experienced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Axel Seher participate in research or clinical trials?
Yes. Axel Seher has published 35 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Axel Seher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- NecrosisMr. Seher isExperienced. Learn about Necrosis.
- Oral Squamous Cell CarcinomaMr. Seher isExperienced. Learn about Oral Squamous Cell Carcinoma.